Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,858 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $512.75 | 10 | $0 (2024) |
| ABBVIE INC. | $337.49 | 14 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $258.23 | 6 | $0 (2024) |
| Alkermes, Inc. | $218.13 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $139.78 | 2 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $89.29 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $78.95 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $56.11 | 3 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $41.30 | 2 | $0 (2024) |
| Lundbeck LLC | $31.24 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,268 | 38 | Otsuka America Pharmaceutical, Inc. ($333.67) |
| 2023 | $465.72 | 18 | Otsuka America Pharmaceutical, Inc. ($179.08) |
| 2021 | $124.93 | 1 | Alkermes, Inc. ($124.93) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: CNS | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: CNS | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $135.88 | General |
| Category: Neuropsychiatry | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Neuropsychiatry | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: ADHD | ||||||
| 05/30/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.63 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 212 | 267 | $53,930 | $17,642 |
| 2022 | 4 | 174 | 191 | $54,118 | $17,447 |
| 2021 | 6 | 275 | 338 | $88,266 | $29,169 |
| 2020 | 1 | 12 | 12 | $4,896 | $1,669 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 53 | $20,024 | $6,082 | 30.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 51 | $11,334 | $4,101 | 36.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 48 | 56 | $8,720 | $2,855 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $6,720 | $2,197 | 32.7% |
| 99498 | Advance care planning, each additional 30 minutes | Facility | 2023 | 22 | 26 | $3,806 | $1,254 | 32.9% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 24 | 56 | $3,326 | $1,152 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 62 | $25,296 | $8,065 | 31.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 77 | $16,170 | $5,257 | 32.5% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 32 | 34 | $7,684 | $2,509 | 32.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $4,968 | $1,616 | 32.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 96 | 97 | $39,576 | $12,978 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 69 | 109 | $22,890 | $7,607 | 33.2% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 57 | 75 | $16,950 | $5,659 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 26 | $3,822 | $1,263 | 33.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $3,588 | $1,195 | 33.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 18 | $1,440 | $466.92 | 32.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,896 | $1,669 | 34.1% |
About Kristyn Fox
Kristyn Fox is a Gerontology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1326670100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristyn Fox has received a total of $1,858 in payments from pharmaceutical and medical device companies, with $1,268 received in 2024. These payments were reported across 57 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,858).
As a Medicare-enrolled provider, Fox has provided services to 673 Medicare beneficiaries, totaling 808 services with total Medicare billing of $65,927. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Location Norfolk, VA
- Active Since 02/10/2020
- Last Updated 11/02/2020
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1326670100
Products in Payments
- REXULTI (Drug) $425.15
- VRAYLAR (Drug) $337.49
- INGREZZA (Drug) $258.23
- LYBALVI (Drug) $124.93
- ABILIFY MAINTENA (Drug) $118.84
- Auvelity (Drug) $109.35
- CAPLYTA (Drug) $101.99
- ARISTADA (Drug) $93.20
- TRINTELLIX (Drug) $78.95
- SPRAVATO (Drug) $56.11
- JORNAY PM (Drug) $41.30
- Sunosi (Drug) $30.43
- Xelstrym (Drug) $24.92
- Dyanavel XR (Drug) $22.14
- QUVIVIQ (Drug) $19.67
- Qelbree (Drug) $15.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Norfolk
Christine Howell, Np, NP
Gerontology — Payments: $4,289
Jean Suehl, Aprn, APRN
Gerontology — Payments: $2,371
Kristine Garcia, Agacnp-Bc, AGACNP-BC
Gerontology — Payments: $373.34
Jessica Duell, Agacnp-Bc, AGACNP-BC
Gerontology — Payments: $293.00
Mr. Curtis Allyne, Arnp, ARNP
Gerontology — Payments: $232.37
Jennifer Kiggans, Agnp, AGNP
Gerontology — Payments: $205.75